Publication:
Flecainide With Ranolazine Combination Inhibits Nav 1.5 Activity of Triple-Negative Breast Cancer Cells (MDA-MB-231)

Simple item page
dc.contributor.authorMAMMADOVA, G.
dc.contributor.authorDEMİREL, M.
dc.contributor.authorALTUN, SEYHAN
dc.date.accessioned2026-01-07T07:08:35Z
dc.date.issued2025
dc.identifier15
dc.identifier.citationMammadova, G., Demirel, M., & Altun, S. (2025, July). Flecainide with ranolazine combination inhibits Nav 1.5 activity of triple-negative breast cancer cells (MDA-MB-231). In FEBS OPEN BIO (Vol. 15, pp. 303-303). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.
dc.identifier.issn2211-5463
dc.identifier.urihttps://hdl.handle.net/11413/9803
dc.identifier.wos001552034503184
dc.language.isoen
dc.publisherWiley
dc.relation.journalFEBS Open Bio
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleFlecainide With Ranolazine Combination Inhibits Nav 1.5 Activity of Triple-Negative Breast Cancer Cells (MDA-MB-231)
dc.typeMeeting Abstract
dspace.entity.typePublication
local.indexed.atWOS
local.journal.endpage303
local.journal.startpage303
relation.isAuthorOfPublicationc146e30a-49bf-440a-8cc4-ba1e3db0c745
relation.isAuthorOfPublication.latestForDiscoveryc146e30a-49bf-440a-8cc4-ba1e3db0c745

Files

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

WoS İndeksli Yayınlar / WoS Indexed Publications
Moleküler Biyoloji ve Genetik Bölümü / Department of Molecular Biology and Genetics